Has there been any feedback yet?
How did it all go?
Antisense Therapeutics Limited ("ANP" or "the Company") is pleased to announce that Dr. Gil Price, the US-based Consultant Medical Director of ANP, the company will be represented at the Food and Drug Administration (FDA) virtual rare disease day event on Friday, March 5, 2021 from 9:00 a.m. to 9:00 p.m. 4 p.m.
Chart, page-3162
-
- There are more pages in this discussion • 2,744 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
